Evolus, Inc. (EOLS)

USD 10.85

(7.32%)

Revenue Summary of Evolus, Inc.

  • Evolus, Inc.'s latest annual revenue in 2023 was 202.08 Million USD , up 35.98% from previous year.
  • Evolus, Inc.'s latest quarterly revenue in 2024 Q1 was 59.33 Million USD , down -2.73% from previous quarter.
  • Evolus, Inc. reported a annual revenue of 148.61 Million USD in annual revenue 2022, up 49.1% from previous year.
  • Evolus, Inc. reported a annual revenue of 99.67 Million USD in annual revenue 2021, up 76.29% from previous year.
  • Evolus, Inc. reported a quarterly revenue of 66.9 Million USD for 2024 Q2, up 12.77% from previous quarter.
  • Evolus, Inc. reported a quarterly revenue of 60.99 Million USD for 2023 Q4, up 23.67% from previous quarter.

Annual Revenue Chart of Evolus, Inc. (2023 - 2015)

Historical Annual Revenue of Evolus, Inc. (2023 - 2015)

Year Revenue Revenue Growth
2023 202.08 Million USD 35.98%
2022 148.61 Million USD 49.1%
2021 99.67 Million USD 76.29%
2020 56.54 Million USD 61.89%
2019 34.92 Million USD 0.0%
2018 - USD 0.0%
2017 - USD 0.0%
2016 - USD 0.0%
2015 - USD 0.0%

Peer Revenue Comparison of Evolus, Inc.

Name Revenue Revenue Difference
Collegium Pharmaceutical, Inc. 566.76 Million USD 64.344%
China SXT Pharmaceuticals, Inc. 1.92 Million USD -10378.886%
Embecta Corp. 1.12 Billion USD 81.97%
Pacira BioSciences, Inc. 674.97 Million USD 70.061%
PainReform Ltd. - USD -Infinity%
Sunshine Biopharma, Inc. 24.09 Million USD -738.778%
SCYNEXIS, Inc. 140.14 Million USD -44.201%
Journey Medical Corporation 79.18 Million USD -155.219%
Safety Shot Inc 202.67 Thousand USD -99611.353%
Alpha Teknova, Inc. 36.68 Million USD -450.88%
Bright Green Corporation 401.49 Thousand USD -50233.631%
Procaps Group, S.A. 409.92 Million USD 50.701%
Alvotech 91.43 Million USD -121.017%
ANI Pharmaceuticals, Inc. 486.81 Million USD 58.488%
Aquestive Therapeutics, Inc. 50.58 Million USD -299.512%
Cosmos Health Inc. 53.37 Million USD -278.6%
Dynavax Technologies Corporation 232.28 Million USD 13.001%
Esperion Therapeutics, Inc. 116.33 Million USD -73.711%
Intra-Cellular Therapies, Inc. 464.37 Million USD 56.482%
Sunshine Biopharma, Inc. 24.09 Million USD -738.778%
Theratechnologies Inc. 81.76 Million USD -147.156%
Harrow Health, Inc. 130.19 Million USD -55.22%
Sonoma Pharmaceuticals, Inc. 12.73 Million USD -1486.847%
Biofrontera Inc. 34.07 Million USD -493.129%
DURECT Corporation 8.54 Million USD -2264.12%
Supernus Pharmaceuticals, Inc. 607.52 Million USD 66.736%
Cronos Group Inc. 88.84 Million USD -127.468%
OptiNose, Inc. 70.98 Million USD -184.679%
Ironwood Pharmaceuticals, Inc. 442.73 Million USD 54.355%
Kala Pharmaceuticals, Inc. - USD -Infinity%
RedHill Biopharma Ltd. 6.51 Million USD -3002.712%
Organogenesis Holdings Inc. 433.14 Million USD 53.344%
Guardion Health Sciences, Inc. 12.24 Million USD -1549.869%
Cumberland Pharmaceuticals Inc. 39.55 Million USD -410.928%
Radius Health, Inc. 2.88 Billion USD 92.989%
Universe Pharmaceuticals INC 32.3 Million USD -525.481%
ProPhase Labs, Inc. 44.38 Million USD -355.31%
Phibro Animal Health Corporation 1.01 Billion USD 80.143%
Procaps Group S.A. 409.92 Million USD 50.701%
TherapeuticsMD, Inc. 1.3 Million USD -15421.121%
Viatris Inc. 15.42 Billion USD 98.69%
Rockwell Medical, Inc. 83.61 Million USD -141.694%
Aytu BioPharma, Inc. 81 Million USD -149.481%
SIGA Technologies, Inc. 139.91 Million USD -44.432%
Tilray Brands, Inc. 788.94 Million USD 74.385%
Lifecore Biomedical, Inc. 128.26 Million USD -57.558%
Shineco, Inc. 9.8 Million USD -1961.701%
PetIQ, Inc. 1.1 Billion USD 81.661%
Regencell Bioscience Holdings Limited - USD -Infinity%
Incannex Healthcare Limited 12 Thousand USD -1683941.667%
Neurocrine Biosciences, Inc. 1.88 Billion USD 89.291%
Alimera Sciences, Inc. 80.75 Million USD -150.248%
Silver Spike Investment Corp. 11.72 Million USD -1623.961%
Assertio Holdings, Inc. 152.06 Million USD -32.89%
Shuttle Pharmaceuticals Holdings, Inc. - USD -Infinity%
Petros Pharmaceuticals, Inc. 5.82 Million USD -3370.827%
Clever Leaves Holdings Inc. 17.41 Million USD -1060.274%
Cyclo Therapeutics, Inc. 1.07 Million USD -18674.067%
Avadel Pharmaceuticals plc 27.96 Million USD -622.687%
Hempacco Co., Inc. 4.04 Million USD -4895.134%
Talphera, Inc. 651 Thousand USD -30942.243%
Alvotech 91.43 Million USD -121.017%
Eagle Pharmaceuticals, Inc. 316.61 Million USD 36.172%
Lantheus Holdings, Inc. 1.29 Billion USD 84.412%
Currenc Group, Inc. 53.25 Million USD -279.464%
Kamada Ltd. 144.75 Million USD -39.601%
Indivior PLC 1.09 Billion USD 81.511%
Evoke Pharma, Inc. 5.18 Million USD -3800.78%
Flora Growth Corp. 76.07 Million USD -165.653%
Cyclo Therapeutics, Inc. 1.07 Million USD -18674.067%
HUTCHMED (China) Limited 837.99 Million USD 75.885%
Amphastar Pharmaceuticals, Inc. 644.39 Million USD 68.64%
Akanda Corp. 2.16 Million USD -9255.562%